trending Market Intelligence /marketintelligence/en/news-insights/trending/MoEXXoS2FbAqZo0MUNsk3g2 content esgSubNav
In This List

Matinas BioPharma appoints director

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Matinas BioPharma appoints director

Matinas BioPharma Holdings Inc. appointed Matthew Wikler to its board, replacing current member Stefano Ferrari, effective Jan. 1, 2018.

Wikler currently serves as the principal of Infectious Disease Technology Development Consulting.